2009European PsychiatryOpen access

The use of Sertraline in Psychiatric Practice

Nikola Radulović, M. Mišković, Dijana Zorić, T. Maglov, Dragan Ilić

Open full text 0 citations

Abstract

Sertraline is an antidepressant of the third generation of the selective serotonin reuptake inhibitor (SSRI) class. It is simple to use and has a wide application in treating various psychiatric disorders, but with much less pronounced side effects. The aim of this study is to establish the frequency and adverse effects in users of sertraline during clinical treatment. The method of work was a prospective study which comprised 30 participants who came for a medical examination for the first time and who had a valid indication for drug suitability. The patients were observed during the following two control check-ups. The findings thus gathered were statistically analysed and shown on the graphs. Conclusion: The examination has shown that the possible side effects of sertraline are rare and mainly of temporary nature, and confirm the effectiveness and safety of sertraline in routine clinical practice.

Open-access reader

About this research paper

What this paper is about

Sertraline is an antidepressant of the third generation of the selective serotonin reuptake inhibitor (SSRI) class. It is simple to use and has a wide application in treating various psychiatric disorders, but with much less pronounced side effects. The aim of this study is to establish the frequency and adverse effects in users of sertraline during clinical treatment. The method of work was a prospective study which comprised 30 participants who came for a medical examination for the first time and who had a valid indication for drug suitability. The patients were observed during the following two control check-ups. The findings thus gathered were statistically analysed and shown on the graphs. Conclusion: The examination has shown that the possible side effects of sertraline are rare and mainly of temporary nature, and confirm the effectiveness and safety of sertraline in routine clinical practice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Sertraline is an antidepressant of the third generation of the selective serotonin reuptake inhibitor (SSRI) class. It is simple to use and has a wide application in treating various psychiatric disorders, but with much less pronounced side effects. The aim of this study is to establish the frequency and adverse effects in users of sertraline during clinical treatment. The method of work was a prospective study which comprised 30 participants who came for a medical examination for the first time and who had a valid indication for drug suitability. The patients were observed during the following two control check-ups. The findings thus gathered were statistically analysed and shown on the graphs. Conclusion: The examination has shown that the possible side effects of sertraline are rare and mainly of temporary nature, and confirm the effectiveness and safety of sertraline in routine clinical practice.

Key concepts: Sertraline, Serotonin reuptake inhibitor, Antidepressant, Psychiatry, Clinical Practice, Medicine, Adverse effect, Drug

Related papers

Back to paper searchBrowse research topicsOriginal source
The use of Sertraline in Psychiatric Practice — Research Paper | ScholarLens